Carregant...
PARP inhibition in UV-associated angiosarcoma preclinical models
PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....
Guardat en:
| Publicat a: | J Cancer Res Clin Oncol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310857/ https://ncbi.nlm.nih.gov/pubmed/34085099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03678-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|